PREVENT 试验:克罗恩病术后复发内镜指数的信度与反应性
基于 PREVENT 试验的 70 段回结肠镜视频,由 3 名盲法中心阅片者评估克罗恩病术后内镜活动。Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 的信度与反应性较好,而 POCER 指数和吻合口 REMIND 评分较差。在吻合口或远端结肠评估时,各指数的信度和反应性均低于新末端回肠。
要点
- Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 信度与反应性较好。
- POCER 指数信度中等、反应性小,吻合口 REMIND 评分信度一般、反应性小。
- 吻合口或远端结肠评估的信度和反应性均低于新末端回肠。
核心结论
- 现有内镜指数在新末端回肠评估克罗恩病术后活动时信度和反应性较好,但在吻合口或远端结肠评估时欠佳。
研究设计与样本
- 基于 PREVENT 试验的 70 段回结肠镜视频,由 3 名盲法中心阅片者独立评估。
- 使用 Rutgeerts 评分、改良 Rutgeerts 评分、POCER 指数、REMIND 评分、SES-CD 和 CDEIS 评估疾病活动。
- 信度用组内相关系数(ICC)量化,反应性用胜率(WinP)量化。
主要发现
- Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 的 ICC 为 0.74-0.80。
- POCER 指数的 ICC 为 0.49,吻合口 REMIND 评分的 ICC 为 0.30。
- Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 的 WinP 为 0.75-0.83。
- POCER 指数和吻合口 REMIND 评分的 WinP 分别为 0.54 和 0.53。
- 在吻合口或远端结肠段评估时,各指数的信度和反应性估计值均低于新末端回肠。
关键数值与推荐
- Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 的 ICC 为 0.74-0.80。
- POCER 指数的 ICC 为 0.49,吻合口 REMIND 评分的 ICC 为 0.30。
- Rutgeerts 评分、改良 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS 的 WinP 为 0.75-0.83。
- POCER 指数和吻合口 REMIND 评分的 WinP 分别为 0.54 和 0.53。
临床怎么用
- 评估克罗恩病术后内镜复发时,优先选用信度和反应性较好的指数(如 Rutgeerts 评分、回肠 REMIND 评分、SES-CD 和 CDEIS)。
- 对吻合口或远端结肠的评估应谨慎解读,因现有指数在该部位的信度和反应性较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Assessing endoscopic activity is integral in the management of postoperative Crohn's disease (CD). We aimed to comprehensively characterize the reliability and responsiveness of different endoscopic instruments when used to assess postoperative CD activity. METHODS: Ileocolonoscopy videos (n = 70) from the PREVENT (Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE ® [infliximab] and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence) trial were reviewed by 3 blinded central readers. Disease activity was assessed using the Rutgeerts and modified Rutgeerts scores, POCER (postoperative Crohn's endoscopic recurrence) index, REMIND (groupe de REcherche sur les Maladies INflammatoires Digestives) score, Simple Endoscopic Score for Crohn's Disease (SES-CD), and the Crohn's Disease Endoscopic Index of Severity (CDEIS). Reliability was quantified by the intraclass correlation coefficient (ICC). Responsiveness was quantified using the win probability (WinP) defined as the probability that a patient in the treatment (infliximab) group had a better score than a patient in the placebo group. The neoterminal ileum, anastomosis, and distal colon were scored separately. RESULTS: Interrater reliability was substantial for the Rutgeerts and modified Rutgeerts scores, ileal REMIND score, SES-CD, and CDEIS (ICC 0.74-0.80), moderate for the POCER index (ICC 0.49), and fair for the anastomotic REMIND score (ICC 0.30). A large degree of responsiveness was observed for the Rutgeerts and modified Rutgeerts scores, ileal REMIND score, SES-CD, and CDEIS (WinP 0.75-0.83). The degree of responsiveness for the POCER index and the anastomotic REMIND score was small (WinP 0.54 and 0.53, respectively). Estimates of index reliability and responsiveness were consistently lower when assessed at the anastomosis or distal colonic segment compared with the neoterminal ileum. CONCLUSIONS: Existing endoscopic indices are reliable and responsive for assessing postoperative CD activity in the neoterminal ileum, although are suboptimal for evaluation in the anastomosis or distal colonic segment.
引用
- Hanzel J, Vuyyuru SK, Bressler B, et al. Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT Trial. Clin Gastroenterol Hepatol. 2025. PMID: 40907850. doi:10.1016/j.cgh.2025.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。